PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

Based on insights from Towards Packaging, the global cell therapy packaging market will likely grow from USD 419.57 million ...

Several European biotechs, including Cellbox Labs, Evotec SE, Nanolive SA, and Salipro Biotech AB, have developed innovative ...

Degradation mechanisms of transcriptionally active aryl hydrocarbon receptor (AHR) are unclear. This work reveals that PARP7 ...

Cryopreservation plays a crucial role in cell biology research, bioprocessing, and biomanufacturing. Traditionally, DMSO ...

What are the physics of life? That is more than just a philosophical question—it has practical implications for our search ...

AUSTIN, Texas and TOKYO, Dec. 1, 2025 /PRNewswire/ -- According to DataM Intelligence, the Hydrogen Fuel Cells Market Size reached USD 3.64 billion in 2024 and is projected to grow to USD 5.9 billion ...

Contract development and manufacturing organization (CDMO) Cellipont announced a partnership with Ronawk, a biotechnology ...

DNA scaffolds that mirror influenza virus protein geometry boost antiviral binding and reduce infection more effectively than free molecules, enabling a modular antiviral design strategy.

Perfecting microbial manufacturing processes means taming its greatest asset: speed. This rapid process for creating ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.